U S Physical Therapy Inc's ability to collect accounts receivable sequentially worsen to 22.4, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. U S Physical Therapy Inc's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 16 days, from 12 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 200 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1492 to 1593.

What is Receivable Turnover Ratio?
What is U S Physical Therapy Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

USPH Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	153.76 %	5.76 %	-9.54 %	18.03 %	26.58 %
Y / Y Revenue Change	8.47 %	7.89 %	12.35 %	17.32 %	18.04 %
Receivable Turnover Ratio (TTM)	22.4	30.94	30.83	29.22	29.11
USPH's Total Ranking	# 1593	# 1492	# 1452	# 1528	# 377
Accounts Receivable average collection period days	16	12	12	12	13
Seq. Receivable Change	151.8 %	14.76 %	1.75 %	-13.7 %	4.95 %
Seq. Revenue Change	7.95 %	-2.19 %	2.84 %	-0.11 %	7.38 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 86
Healthcare Sector	# 201
Overall Market	# 1593

Receivable Turnover Ratio Statistics
High	Average	Low
1.54	0.95	0.4
(Sep 30 2012)

USPH Company Profile • Back to USPH Efficiency Comparisons • Compare USPH Receivables Turnover Ratio to its Competitors

Financial Statements
U S Physical Therapy Inc's Accounts Receivable	$ 70 Millions	Visit USPH's Balance sheet
U S Physical Therapy Inc's Sales TTM	$ 812 Millions	Visit USPH's Income Statement
Sources of USPH's Revenues		Visit USPH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
USPH's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
USPH's Growth Rates	USPH's Roa	USPH's Inventory Turnover Ratio	USPH's Dividend Comparisons
USPH's Profitability Ratios	USPH's Roi	USPH's Asset Turnover Ratio	USPH's Dividend Growth
USPH's Valuation Ratios	USPH's Roe	USPH's Financial Strength Ratios	USPH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Innovative Eyewear Inc	31.49	$ 3.412 Millions	$ 0.108 Millions
Mangoceuticals Inc	31.43	$ 0.315 Millions	$ 0.010 Millions
Cv Sciences Inc	31.22	$ 12.066 Millions	$ 0.387 Millions
Jaguar Health Inc	30.23	$ 27.815 Millions	$ 0.920 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions
Metagenomi Therapeutics Inc	25.05	$ 13.561 Millions	$ 0.541 Millions
Sonida Senior Living Inc	22.59	$ 525.973 Millions	$ 23.283 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Lipocine Inc	18.36	$ 1.569 Millions	$ 0.085 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Vireo Growth Inc.	16.69	$ 511.706 Millions	$ 30.659 Millions
Agenus Inc	15.44	$ 132.693 Millions	$ 8.595 Millions
Longeveron Inc	15.03	$ 1.187 Millions	$ 0.079 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Dar Bioscience Inc	14.57	$ 1.345 Millions	$ 0.092 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
China Pharma Holdings Inc	14.46	$ 3.914 Millions	$ 0.271 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Corcept Therapeutics Inc	13.30	$ 830.813 Millions	$ 62.477 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions
Petvivo Holdings Inc	12.34	$ 1.182 Millions	$ 0.096 Millions
Alpha Pro Tech Ltd	12.25	$ 62.204 Millions	$ 5.077 Millions
Vivos Therapeutics Inc	12.21	$ 21.135 Millions	$ 1.731 Millions

Date modified: 2026-08-31T04:06:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.